Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum 		Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
The beginning of the paradigm change for MS specialists and pharma? Stanford's...
Monday, March 5, 2012 7:16 PM | CCSVI in Multiple Sclerosis Volg link
The beginning of the paradigm change for MS specialists and pharma? Stanford's professor Steinman and the clinical trial of Lisinopril, an inexpensive blood pressure medication, for MS.


Transparency Life Sciences Obtains Exclusive Option from Stanford University for use of Lisinopril i
www.marketwatch.com